Expert Consultants

David Ashkin, M.D., National TB Controllers Association and A.G. Holley State Tuberculosis Hospital Lantana, Florida
A. Cornelius Baker, National Association of Persons with AIDS, Washington, D.C.
Peter E. Barnes, M.D., Center for Pulmonary and Infectious Disease Control, University of Texas, Tyler, Texas
Debra A. Benator, M.D., Veterans Administration Medical Center, Washington, D.C.
Naomi N. Bock, M.D., M.S., Emory University School of Medicine, Atlanta, Georgia
Williamson Z. Bradford, M.D., M.P.H., University of California at San Francisco, San Francisco, California
William J. Burman, M.D., Denver Department of Health and Hospitals, Denver, Colorado
Joseph Burzynski, M.D., Bedford Chest Clinic, Brooklyn, New York
Richard E. Chaisson, M.D., Johns Hopkins University School of Medicine, Baltimore, Maryland
Daniel P. Chin, M..D., M.P.H., California Department of Health Services, Berkeley, California
David Cohn, M.D., Denver Department of Health and Hospitals, Denver, Colorado
Charles L. Daley, M.D., University of California at San Francisco, San Francisco, California
Richard Ehara, National Minority AIDS Council, Washington, D.C.
Wafaa M. El-Sadr, M.D., M.P.H., M.P.A., CDC Advisory Council for the Elimination of TB and Harlem Hospital Center, New York, New York
Keith D. Gallicano, Ph.D., Ottawa General Hospital, Ottawa, Ontario, Canada
Jeffrey Glassroth, M.D., Allegheny University Hospital, Philadelphia, Pennsylvania
Mark J. Goldberger, M.D., Food and Drug Administration, Rockville, Maryland
Fred M. Gordin, M.D., Veterans Administration Medical Center, Washington, D.C.
Marc N. Gourevitch, M.D., M.P.H., Montefiore Medical Center, Bronx, New York
Jacques H. Grosset, M.D., Laboratoire Bacteriologie, Groupe Hospitalier Pitie-Salpetriere, Paris, France
James L. Hadler, M.D., M.P.H., Council of State and Territorial Epidemiologists and Department of Public Health Hartford, Connecticut
Diane V. Havlir, M.D., University of California at San Diego Medical Center, San Diego, California